The Living Tree

Sachin Chaturvedi is a Senior Fellow at the Research and Information System for Developing Countries (RIS), a think tank with the Government of India’s Ministry of External Affairs. He works on, inter alia, development cooperation policies and South-South cooperation, and science, technology and innovation policies. Miltos Ladikas currently holds Research Fellow posts at the Centre for Professional Ethics, University of Central Lancashire, UK and the Institute for Technology Assessment and Systems Analysis, Karlsruhe Institute of Technology, Germany. His professional background covers the areas of technology assessment, public perceptions of S&T, ethics in S&T policy and science and development. Guo Lifeng is Associate Professor, Chinese Academy of Science and Technology for Development (CASTED), Ministry of Science and Technology, Beijing, China. Her research interests include science and technology polices and IPR issue in International trade. Krishna Ravi Srinivas is an Associate Fellow with RIS, a policy research think tank based in New Delhi, India. He has written on, inter alia, IPRs, open source and open innovation models, traditional knowledge, and climate change and technology transfer.

Foreword A.P.J. Abdul Kalam
Preface Biswajit Dhar
Introduction
Health Sector Challenges, Traditional Medicines and India China Collaboration
Section I: Health Impact Fund
1. The Health Impact Fund: Issues and Challenges
2. Stakeholder Views Regarding the Objectives and Implementation of the HIF
3. Health Impact of New Pharmaceutical Pro-ducts in the Context of Health Impact Funds
4. Gender-based Barriers to Access to Health Care and Medicine: The Case of India and China
Section II: India
5. Intellectual Property Rights and Traditional Chinese Medicine: The Experience in China and What India can learn from that
6. Dynamics of Traditional Medicine Industry: Issues in Trade, Technology and Standards
7. Regulatory Guidelines for Traditional Medicines in India
8. Traditional Medicine and Intellectual Property Policies
Section III: China
9. China-India Cooperation on Intellectual Property Protection of Traditional Medicines
10. Industrial Development: External Trade and R&D of Traditional Chinese Medicine
11. Traditional Drug: Standard and Basic Medicine System of China
12. Public Health Problem and Development of Traditional Medicine
Section IV: Conclusion
13. Potential or China-India Cooperation and HIF: Concluding Remarks and Policy Recommendations